Chevret S - Search Results

1

Dose-finding design driven by efficacy in onco-hematology phase I/II trials.

Seegers V, Chevret S, Resche-Rigon M. Seegers V, et al. Among authors: chevret s. Stat Med. 2011 Jun 15;30(13):1574-83. doi: 10.1002/sim.4152. Epub 2011 Mar 11. Stat Med. 2011. PMID: 21394754

2

Multiple imputation: a mature approach to dealing with missing data.

Chevret S, Seaman S, Resche-Rigon M. Chevret S, et al. Intensive Care Med. 2015 Feb;41(2):348-50. doi: 10.1007/s00134-014-3624-x. Epub 2015 Jan 13. Intensive Care Med. 2015. PMID: 25578679 Free PMC article. No abstract available.

3

Investigating covariate-by-centre interaction in survival data.

Biard L, Labopin M, Chevret S, Resche-Rigon M; Acute Leukaemia Working Party of the EBMT. Biard L, et al. Among authors: chevret s. Stat Methods Med Res. 2018 Mar;27(3):920-932. doi: 10.1177/0962280216647981. Epub 2016 May 10. Stat Methods Med Res. 2018. PMID: 27166409

4

Recent developments in adaptive designs for Phase I/II dose-finding studies.

Zohar S, Chevret S. Zohar S, et al. Among authors: chevret s. J Biopharm Stat. 2007;17(6):1071-83. doi: 10.1080/10543400701645116. J Biopharm Stat. 2007. PMID: 18027217

5

Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study.

O'Quigley J, Chevret S. O'Quigley J, et al. Among authors: chevret s. Stat Med. 1991 Nov;10(11):1647-64. doi: 10.1002/sim.4780101104. Stat Med. 1991. PMID: 1792460 Review.

6

The continual reassessment method in cancer phase I clinical trials: a simulation study.

Chevret S. Chevret S. Stat Med. 1993 Jun 30;12(12):1093-108. doi: 10.1002/sim.4780121201. Stat Med. 1993. PMID: 8210815

7

Evaluating mortality in intensive care units: contribution of competing risks analyses.

Resche-Rigon M, Azoulay E, Chevret S. Resche-Rigon M, et al. Among authors: chevret s. Crit Care. 2006 Feb;10(1):R5. doi: 10.1186/cc3921. Crit Care. 2006. PMID: 16356211 Free PMC article.

8

The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies.

Zohar S, Chevret S. Zohar S, et al. Among authors: chevret s. Stat Med. 2001 Oct 15;20(19):2827-43. doi: 10.1002/sim.920. Stat Med. 2001. PMID: 11568943

9

Measures of treatment effectiveness on tumour response and survival: a multi-state model approach.

Chevret S, Leporrier M, Chastang C. Chevret S, et al. Stat Med. 2000 Mar 30;19(6):837-48. doi: 10.1002/(sici)1097-0258(20000330)19:6<837::aid-sim394>3.0.co;2-3. Stat Med. 2000. PMID: 10734287 Clinical Trial.

10

Analysis of recurrent failure times data: should the baseline hazard be stratified?

Mahé C, Chevret S. Mahé C, et al. Among authors: chevret s. Stat Med. 2001 Dec 30;20(24):3807-15. doi: 10.1002/sim.909. Stat Med. 2001. PMID: 11782035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters